SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016666
Filing Date
2022-11-08
Accepted
2022-11-07 17:36:01
Documents
92
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akya-20220930x10q.htm   iXBRL 10-Q 2846885
2 EX-31.1 akya-20220930xex31d1.htm EX-31.1 14850
3 EX-31.2 akya-20220930xex31d2.htm EX-31.2 14907
4 EX-32.1 akya-20220930xex32d1.htm EX-32.1 6816
5 EX-32.2 akya-20220930xex32d2.htm EX-32.2 7832
  Complete submission text file 0001558370-22-016666.txt   10695460

Data Files

Seq Description Document Type Size
6 EX-101.SCH akya-20220930.xsd EX-101.SCH 61480
7 EX-101.CAL akya-20220930_cal.xml EX-101.CAL 77410
8 EX-101.DEF akya-20220930_def.xml EX-101.DEF 270720
9 EX-101.LAB akya-20220930_lab.xml EX-101.LAB 563045
10 EX-101.PRE akya-20220930_pre.xml EX-101.PRE 460780
86 EXTRACTED XBRL INSTANCE DOCUMENT akya-20220930x10q_htm.xml XML 1988680
Mailing Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762
Business Address 100 CAMPUS DRIVE 6TH FLOOR MARLBOROUGH MA 01762 855.896.8401
Akoya Biosciences, Inc. (Filer) CIK: 0001711933 (see all company filings)

IRS No.: 475586242 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40344 | Film No.: 221366618
SIC: 3826 Laboratory Analytical Instruments